The number of shares and votes in XVIVO Perfusion AB (publ) has during May 2019 increased by 198,000 shares and votes as a result of warrants being exercised as part of the company’s 2017 incentive program. As of May 31, 2019 there are thus in total 26,600,496 shares and votes in the company.
May 31, 2019
Gothenburg
Christoffer Rosenblad, CFO
XVIVO Perfusion AB (publ)
For further information please contact:
Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com
Magnus Nilsson, CEO, +46 31 788 2150, magnus.nilsson@xvivoperfusion.com
For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com
This information is information that Xvivo Perfusion AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 8.30 am CET on May 31, 2019.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.